GlassScriptPhysician profile
Marc Benjamin Danziger
NPI 1346308236
$862.33
in general payments reported to CMS, 2019-2025
9 companies · $89.42 in 2025
The $89.42 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $338 · 2022: $91.40 · 2023: $325 · 2024: $18.74 · 2025: $89.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $432.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $398.13 | 2019-2023 | Serfas Energy, Cobra, Cinchlock |
| Depuy Synthes Sales INC. | $246.86 | 2019-2023 | Rigidloop, Healix Knotless Peek, Rigidfix |
| Pacira Pharmaceuticals Incorporated | $113.66 | 2023-2025 | Exparel, Zilretta, Iovera |
| Ermi LLC | $20.71 | 2019 | |
| Smith+Nephew, INC. | $19.96 | 2025 | Renasys Go V2 Home, Pico 14 |
| Medline Industries LP | $18.74 | 2024 | |
| Bioventus LLC | $16.75 | 2019 | |
| Boston Scientific Corporation | $14.28 | 2023 | Wavewriter Alpha Prime 16 |
| Checkpoint Surgical, INC | $13.24 | 2025 | Checkpoint Stimulators |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Danziger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.